Pfizer’s BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term Survival in Patients with ...

Pfizer Inc. (NYSE: PFE) today announced updated follow-up results from the single-arm Phase 2 PHAROS trial evaluating ...
New Telegraph

Isseke: Taking Their Peace Back With Force

Since the month of September, there have been recovery of towns in Ihiala Local Government Area of Anambra State from unknown ...